Fine-tuning activation specificity of G-protein-coupled receptors via automated path searching

受体 G蛋白偶联受体 化学 S1PR1型 生物发光 锚蛋白重复序列 生物系统 生物物理学 生物 生物化学 基因 癌症研究 血管内皮生长因子A 血管内皮生长因子 血管内皮生长因子受体
作者
Rujuan Ti,Bin Pang,Leiye Yu,Bing Siang Gan,Wenzhuo Ma,Arieh Warshel,Ruobing Ren,Lizhe Zhu
出处
期刊:Proceedings of the National Academy of Sciences of the United States of America [National Academy of Sciences]
卷期号:121 (8): e2317893121-e2317893121 被引量:11
标识
DOI:10.1073/pnas.2317893121
摘要

Physics-based simulation methods can grant atomistic insights into the molecular origin of the function of biomolecules. However, the potential of such approaches has been hindered by their low efficiency, including in the design of selective agonists where simulations of myriad protein–ligand combinations are necessary. Here, we describe an automated input-free path searching protocol that offers (within 14 d using Graphics Processing Unit servers) a minimum free energy path (MFEP) defined in high-dimension configurational space for activating sphingosine-1-phosphate receptors (S1PRs) by arbitrary ligands. The free energy distributions along the MFEP for four distinct ligands and three S1PRs reached a remarkable agreement with Bioluminescence Resonance Energy Transfer (BRET) measurements of G-protein dissociation. In particular, the revealed transition state structures pointed out toward two S1PR3 residues F263/I284, that dictate the preference of existing agonists CBP307 and BAF312 on S1PR1/5. Swapping these residues between S1PR1 and S1PR3 reversed their response to the two agonists in BRET assays. These results inspired us to design improved agonists with both strong polar head and bulky hydrophobic tail for higher selectivity on S1PR1. Through merely three in silico iterations, our tool predicted a unique compound scaffold. BRET assays confirmed that both chiral forms activate S1PR1 at nanomolar concentration, 1 to 2 orders of magnitude less than those for S1PR3/5. Collectively, these results signify the promise of our approach in fine agonist design for G-protein-coupled receptors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潇洒青荷发布了新的文献求助10
刚刚
刚刚
1秒前
Limerence完成签到,获得积分10
1秒前
flyingdragon完成签到,获得积分10
1秒前
超超完成签到,获得积分20
2秒前
Ceng完成签到,获得积分10
2秒前
2秒前
3秒前
笑点低的一一完成签到,获得积分10
3秒前
3秒前
复杂的觅波完成签到,获得积分10
3秒前
大个应助张春梦紫采纳,获得10
3秒前
Hello应助liqiang采纳,获得10
3秒前
4秒前
5秒前
xdf发布了新的文献求助10
6秒前
6秒前
6秒前
7秒前
7秒前
7秒前
丘比特应助笑点低的一一采纳,获得10
7秒前
英勇的吐司完成签到,获得积分10
7秒前
8秒前
8秒前
忧郁的梦琪完成签到,获得积分20
8秒前
CodeCraft应助中国大陆采纳,获得10
8秒前
Copyright应助sube采纳,获得10
9秒前
充电宝应助li_xiao_mu采纳,获得80
9秒前
从容的完成签到 ,获得积分10
9秒前
吱哦周发布了新的文献求助10
9秒前
无限的民完成签到,获得积分10
10秒前
11秒前
11秒前
壹叁发布了新的文献求助10
11秒前
Tomice发布了新的文献求助10
12秒前
liqiang完成签到,获得积分20
12秒前
mouse完成签到,获得积分10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6953943
求助须知:如何正确求助?哪些是违规求助? 8637786
关于积分的说明 18317294
捐赠科研通 6398044
什么是DOI,文献DOI怎么找? 3083051
关于科研通互助平台的介绍 2129007
邀请新用户注册赠送积分活动 2059872